Probing mechanisms that underlie human neurodegenerative diseases in Drosophila

Annual Review of Genetics

Volumn 46, Issue , 2012, Pages 371-396

  Jaiswal, M ^a   Sandoval, H ^a   Zhang, K ^a   Bayat, V ^a   Bellen, H J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; CHAPERONE; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN; PINK1 PROTEIN; POLYGLUTAMINE; PROTEASOME; PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UBIQUITIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CYTOTOXICITY; DEGENERATIVE DISEASE; DROSOPHILA; ELECTRORETINOGRAM; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC SCREENING; HUNTINGTON CHOREA; LIFESPAN; MITOPHAGY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHOTOTAXIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUALITY CONTROL; REVIEW;

ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; LONGEVITY; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; SYNAPTIC TRANSMISSION; UBIQUITIN;

DROSOPHILA MELANOGASTER; METAZOA;

EID: 84870159570     PISSN: 00664197     EISSN: 15452948     Source Type: Book Series    
DOI: 10.1146/annurev-genet-110711-155456     Document Type: Review

References (213)

1. Agrawal N, Pallos J, Slepko N, Apostol BL, Bodai L, et al. 2005. Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl. Acad. Sci. USA 102:3777-81
2. Akassoglou K, Malester B, Xu J, Tessarollo L, Rosenbluth J, Chao MV. 2004. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc.Natl. Acad. Sci.USA101:5075- 80
3. Ali YO, Ruan K, Zhai RG. 2011. NMNAT suppresses Tau-induced neurodegeneration by promoting clearance of hyperphosphorylated Tau oligomers in a Drosophila model of tauopathy. Hum. Mol. Genet. 21:237-50
4. Anagnostou G, Akbar MT, Paul P, Angelinetta C, Steiner TJ, de Belleroche J. 2010. Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 31:969-85
5. Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, et al. 2007. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 104:14807-12
6. Araki T, Sasaki Y, Milbrandt J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-13
7. Bahadorani S, Hilliker AJ. 2008. Antioxidants cannot suppress the lethal phenotype of a Drosophila melanogaster model of Huntington's disease. Genome 51:392-95
8. Barone MC, Sykiotis GP, Bohmann D. 2011. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. Dis. Model. Mech. 4:701-7
9. Bayat V, Jaiswal M, Bellen HJ. 2010. The BMP signaling pathway at the Drosophila neuromuscular junction and its links to neurodegenerative diseases. Curr. Opin. Neurobiol. 21:182-88
10. Bayat V, Thiffault I, Jaiswal M, Tetreault M, Donti T, et al. 2012. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol. 10:e1001288
11. Benzer S. 1967. Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc. Natl. Acad. Sci. USA 58:1112-19
12. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, et al. 2006. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15:433-42
13. Bertram L, Lill CM, Tanzi RE. 2010. The genetics of Alzheimer disease: back to the future. Neuron 68:270-81
14. BessonMT, Dupont P, Fridell YW, Lievens JC. 2010. Increased energymetabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease. Hum. Mol. Genet. 19:3372-82
15. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-6
16. Bettencourt daCruz A, Wentzell J, Kretzschmar D. 2008. SwissCheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3. J. Neurosci. 28:10885-92
17. Bilen J, Bonini NM. 2007. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 3:1950-64
18. Blumenthal EM. 2008. Cloning of the neurodegeneration gene drop-dead and characterization of additional phenotypes of its mutation. Fly 2:180-88
19. Boillee S, Vande Velde C, ClevelandDW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59
20. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. 2003. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256-59
21. Bonini NM, Fortini ME. 2003. Human neurodegenerative diseasemodeling using Drosophila. Annu. Rev. Neurosci. 26:627-56
22. Bonner JM, Boulianne GL. 2011. Drosophila as amodel to study age-related neurodegenerative disorders: Alzheimer's disease. Exp. Gerontol. 46:335-39
23. Botella JA, Bayersdorfer F, Schneuwly S. 2008. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 30:65-73
24. Botella JA, Kretzschmar D, Kiermayer C, Feldmann P, Hughes DA, Schneuwly S. 2003. Deregulation of the Egfr/Ras signaling pathway induces age-related brain degeneration in the Drosophila mutant vap. Mol. Biol. Cell 14:241-50
25. Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, et al. 2006. Early-onsetAlzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. Arch. Neurol. 63:1307-11
26. Broen JC, Coenen MJ, Radstake TR. 2011. Deciphering the genetic background of systemic sclerosis. Expert Rev. Clin. Immunol. 7:449-62
27. Browne SE, Beal MF. 2006. Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox Signal. 8:2061-73
28. Buchanan RL, Benzer S. 1993. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron 10:839-50
29. Bueler H. 2010. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis 15:1336-53
30. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, et al. 1999. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65:664-70
31. Celotto AM, Frank AC, Seigle JL, Palladino MJ. 2006. Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy. Genetics 174:1237-46
32. Chai A, Withers J, Koh YH, Parry K, Bao H, et al. 2008. hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol. Genet. 17:266-80
33. Chan HY, Warrick JM, Andriola I, Merry D, Bonini NM. 2002. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11:2895-904
34. Chang JT, Milligan S, Li Y, Chew CE, Wiggs J, et al. 1997. Mammalian homolog of Drosophila retinal degeneration B rescues the mutant fly phenotype. J. Neurosci. 17:5881-90
35. Chang YY, Neufeld TP. 2010. Autophagy takes flight in Drosophila. FEBS Lett. 584:1342-49
36. Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, et al. 2003. Interaction of Aktphosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113:457-68
37. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. 2006. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-66
38. Coombe PE, Heisenberg M. 1986. The structural brain mutant Vacuolar medulla of Drosophila melanogaster with specific behavioral defects and cell degeneration in the adult. J. Neurogenet. 3:135- 58
39. Coulom H, Birman S. 2004. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J. Neurosci. 24:10993-98
40. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, et al. 2005. Intraneuronal Aβnon-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132:123-35
41. Dachsel JC, Farrer MJ. 2010. LRRK2 and Parkinson disease. Arch. Neurol. 67:542-47
42. de Belle JS, Heisenberg M. 1996. Expression of Drosophila mushroom body mutations in alternative genetic backgrounds: a case study of the mushroom body miniature gene (mbm). Proc. Natl. Acad. Sci. USA 93:9875-80
43. de Carvalho AP, Sweadner KJ, Penniston JT, Zaremba J, Liu L, et al. 2004. Mutations in the Na+/K+- ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43:169-75
44. Deng H, DodsonMW, Huang H, GuoM. 2008. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. USA 105:14503-8
45. Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB. 2007. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 117:236-45
46. Ding M, Shen K. 2008. The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases. Bioessays 30:1075-83
47. Dittman J. 2009. Worm watching: imaging nervous system structure and function in Caenorhabditis elegans. Adv. Genet. 65:39-78
48. Dobyns WB, Ozelius LJ, Kramer PL, Brashear A, Farlow MR, et al. 1993. Rapid-onset dystonia parkinsonism. Neurology 43:2596-602
49. Dupuis L, Loeffler JP. 2009. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol. 9:341-46
50. Elia AJ, Parkes TL, Kirby K, St George-Hyslop P, Boulianne GL, et al. 1999. Expression of human FALS SOD in motorneurons of Drosophila. Free Radic. Biol. Med. 26:1332-38
51. Feany MB, Bender WW. 2000. A Drosophila model of Parkinson's disease. Nature 404:394-98
52. Fergestad T, Bostwick B, Ganetzky B. 2006. Metabolic disruption in Drosophila bang-sensitive seizure mutants. Genetics 173:1357-64
53. Fergestad T, Olson L, Patel KP, Miller R, Palladino MJ, Ganetzky B. 2008. Neuropathology in Drosophila mutants with increased seizure susceptibility. Genetics 178:947-56
54. Fernandes C, Rao Y. 2011. Genome-wide screen formodifiers of Parkinson's disease genes in Drosophila. Mol. Brain 4:17
55. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, et al. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101-6
56. Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M. 2004. A model for studying Alzheimer's Aβ42- induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 26:365-75
57. Ganetzky B, Wu CF. 1982. Indirect suppression involving behavioral mutants with altered nerve excitability in Drosophila melanogaster. Genetics 100:597-614
58. Gnerer JP, Kreber RA, Ganetzky B. 2006. wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death. Proc. Natl. Acad. Sci. USA 103:14987-93
59. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. 2003. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100:4078-83
60. Grosskreutz J, Van Den Bosch L, Keller BU. 2010. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47:165-74
61. Guo M. 2010. What have we learned from Drosophila models of Parkinson's disease? Prog. Brain Res. 184:3-16
62. Han SM, Tsuda H, Yang Y, Vibbert J, Cottee P, et al. 2012. Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell 22:348-62
63. Hao LY, Giasson BI, Bonini NM. 2010. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc. Natl. Acad. Sci. USA 107:9747-52
64. Harman D. 1956. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11:298-300
65. Harman D. 2006. Alzheimer's disease pathogenesis: role of aging. Ann. NY Acad. Sci. 1067:454-60
66. Havekes R, Abel T. 2009. Genetic dissection of neural circuits and behavior in Mus musculus. Adv. Genet. 65:1-38
67. Heisenberg M, Bohl K. 1979. Isolation of anatomical brain mutants of Drosophila by histological means. Z. Naturforsch. B 34:143-47
68. Hotta Y, Benzer S. 1969. Abnormal electroretinograms in visual mutants of Drosophila. Nature 222:354- 56
69. Hotta Y, Benzer S. 1970. Genetic dissection of the Drosophila nervous system by means of mosaics. Proc. Natl. Acad. Sci. USA 67:1156-63
70. Hotta Y, Benzer S. 1972. Mapping of behaviour in Drosophila mosaics. Nature 240:527-35
71. Hull-Thompson J, Muffat J, Sanchez D, Walker DW, Benzer S, et al. 2009. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet. 5:e1000460
72. Hurley JH. 2010. The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 45:463-87
73. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. 2004. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: a potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101:6623-28
74. Iijima-Ando K, Hearn SA, Shenton C, Gatt A, Zhao L, Iijima K. 2009. Mitochondrial mislocalization underlies Aβ42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 4:e8310
75. Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, et al. 2008. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 27:2432-43
76. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, et al. 1998. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21:633-42
77. Judd BH, ShenMW, Kaufman TC. 1972. The anatomy and function of a segment of the X chromosome of Drosophila melanogaster. Genetics 71:139-56
78. Juhasz G, Erdi B, Sass M, Neufeld TP. 2007. Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev. 21:3061-66
79. Kahle PJ, Waak J, Gasser T. 2009. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic. Biol. Med. 47:1354-61
80. Karbowski M, Neutzner A. 2012. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol. 123:157-71
81. Kazemi-Esfarjani P, Benzer S. 2000. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287:1837-40
82. Kim S, Wairkar YP, Daniels RW, DiAntonio A. 2010. The novel endosomal membrane protein Ema interacts with the classCVps-HOPS complex to promote endosomal maturation. J. Cell Biol. 188:717-34
83. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-8
84. Kretzschmar D. 2009. Swiss Cheese et allii, some of the first neurodegenerative mutants isolated in Drosophila. J. Neurogenet. 23:34-41
85. Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. 1997. The Swiss Cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J. Neurosci. 17:7425-32
86. Langston JW, Ballard P, Tetrud JW, Irwin I. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-80
87. Lavara-Culebras E, Munoz-Soriano V, Gomez-Pastor R, Matallana E, Paricio N. 2010. Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1β mutants. Gene 462:26-33
88. Lavara-Culebras E, Paricio N. 2007. Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits. Gene 400:158-65
89. Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. 2007. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 17:1561-67
90. Lee WC, Yoshihara M, Littleton JT. 2004. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model ofHuntington's disease. Proc. Natl. Acad. Sci. USA 101:3224-29
91. Legan SK, Rebrin I, Mockett RJ, Radyuk SN, Klichko VI, et al. 2008. Overexpression of glucose-6- phosphate dehydrogenase extends the life span of Drosophila melanogaster. J. Biol. Chem. 283:32492-99
92. Lessing D, Bonini NM. 2009. Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants. Nat. Rev. Genet. 10:359-70
93. Liao PC, Lin HY, Yuh CH, Yu LK, Wang HD. 2008. The effect of neuronal expression of heat shock proteins 26 and 27 on lifespan, neurodegeneration, and apoptosis in Drosophila. Biochem. Biophys. Res. Commun. 376:637-41
94. Lill CM, Abel O, Bertram L, Al-Chalabi A. 2011. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph. Lateral Scler. 12:238-49
95. Lin MT, Beal MF. 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-95
96. Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM. 2009. Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4:e4201
97. Liu W, Acin-Perez R, Geghman KD, Manfredi G, Lu B, Li C. 2011. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. USA 108:12920-24
98. Liu Z, Wang X, Yu Y, Li X, Wang T, et al. 2008. A Drosophila model for LRRK2-linked parkinsonism. Proc. Natl. Acad. Sci. USA 105:2693-98
99. Long J, Gao H, Sun L, Liu J, Zhao-Wilson X. 2009. Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. Rejuvenation Res. 12:321-31
100. Luo L, Callaway EM, Svoboda K. 2008. Genetic dissection of neural circuits. Neuron 57:634-60
101. Lush MJ, Li Y, Read DJ, Willis AC, Glynn P. 1998. Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem. J. 332:1-4
102. Mallik M, Lakhotia SC. 2010. Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models. J. Genet. 89:497-526
103. Mehta SQ, Hiesinger PR, Beronja S, Zhai RG, Schulze KL, et al. 2005. Mutations in Drosophila sec15 reveal a function in neuronal targeting for a subset of exocyst components. Neuron 46:219-32
104. Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, et al. 2011. Priorities in Parkinson's disease research. Nat. Rev. Drug Discov. 10:377-93
105. Melendez A, Neufeld TP. 2008. The cell biology of autophagy in metazoans: a developing story. Development 135:2347-60
106. Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, et al. 2005. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15:1572-77
107. Midorikawa R, Yamamoto-Hino M, AwanoW, Hinohara Y, Suzuki E, et al. 2010. Autophagy-dependent rhodopsin degradation prevents retinal degeneration in Drosophila. J. Neurosci. 30:10703-19
108. Miller DW, Cookson MR, Dickson DW. 2004. Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol. 1:13-21
109. Min KT, Benzer S. 1997. Spongecake and eggroll: two hereditary diseases in Drosophila resemble patterns of human brain degeneration. Curr. Biol. 7:885-88
110. Min KT, Benzer S. 1999. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science 284:1985-88
111. Mitne-Neto M, Machado-Costa M, Marchetto MC, Bengtson MH, Joazeiro CA, et al. 2011. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 20:3642-52
112. Moore DJ, Dawson VL, Dawson TM. 2006. Lessons from Drosophila models of DJ-1 deficiency. Sci. Aging Knowl. Environ. 2006:pe2
113. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, et al. 2009. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.EMBOMol.Med. 1:99-111
114. Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, et al. 2004. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry 9:522-30
115. Muffat J, Walker DW. 2010. Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle 9:269-73
116. Muffat J, Walker DW, Benzer S. 2008. Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc. Natl. Acad. Sci. USA 105:7088-93
117. Muhlig-Versen M, da Cruz AB, Tschape JA, Moser M, Buttner R, et al. 2005. Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J. Neurosci. 25:2865-73
118. Narendra D, Tanaka A, Suen DF, Youle RJ. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183:795-803
119. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, et al. 2004. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75:822-31
120. Nistico R, Mehdawy B, Piccirilli S, MercuriN. 2011. Paraquat- and rotenone-induced models of Parkinson's disease. Int. J. Immunopathol. Pharmacol. 24:313-22
121. Nixon RA. 2007. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 120:4081-91
122. Orosz F, Olah J, Ovadi J. 2009. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim. Biophys. Acta 1792:1168-74
123. Orr HT, Zoghbi HY. 2007. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30:575-621
124. Owusu-Ansah E, Yavari A, Mandal S, Banerjee U. 2008. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat. Genet. 40:356-61
125. Pak WL, Grossfield J, White NV. 1969. Nonphototactic mutants in a study of vision of Drosophila. Nature 222:351-54
126. Palladino MJ, Bower JE, Kreber R, Ganetzky B. 2003. Neural dysfunction and neurodegeneration in Drosophila Na+/K+ ATPase alpha subunit mutants. J. Neurosci. 23:1276-86
127. Palladino MJ, Hadley TJ, Ganetzky B. 2002. Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila. Genetics 161:1197-208
128. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, et al. 2007. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859-63
129. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, et al. 2002. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5:731-36
130. Park J, Kim SY, Cha GH, Lee SB, Kim S, Chung J. 2005. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361:133-39
131. Park SS, Schulz EM, Lee D. 2007. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α-synuclein. Eur. J. Neurosci. 26:3104-12
132. Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, Boulianne GL. 1998. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19:171-74
133. Parkinson N, Ince PG, SmithMO, Highley R, Skibinski G, et al. 2006. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67:1074-77
134. Parron T, Requena M, Hernandez AF, Alarcon R. 2011. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol. Appl. Pharmacol. 256:379-85
135. Paul A, Belton A, Nag S, Martin I, Grotewiel MS, Duttaroy A. 2007. Reduced mitochondrial SOD displays mortality characteristics reminiscent of natural aging. Mech. Ageing Dev. 128:706-16
136. Pennetta G, Hiesinger PR, Fabian-Fine R, Meinertzhagen IA, Bellen HJ. 2002. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependentmanner. Neuron 35:291-306
137. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al. 2004. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131:2183-94
138. Pienaar IS, Gotz J, Feany MB. 2010. Parkinson's disease: insights from non-traditionalmodel organisms. Prog. Neurobiol. 92:558-71
139. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-47
140. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ. 2008. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA 105:1638-43
141. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L. 2010. Themitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 5:e10054
142. Preville X, Salvemini F, Giraud S, Chaufour S, Paul C, et al. 1999. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp. Cell Res. 247:61-78
143. Rainier S, Bui M, Mark E, Thomas D, Tokarz D, et al. 2008. Neuropathy target esterase genemutations cause motor neuron disease. Am. J. Hum. Genet. 82:780-85
144. Ratnaparkhi A, Lawless GM, Schweizer FE, Golshani P, Jackson GR. 2008. A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS One 3:e2334
145. Ravikumar B, Imarisio S, Sarkar S, O'Kane CJ, Rubinsztein DC. 2008. Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J. Cell Sci. 121:1649-60
146. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. 2004. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly andmousemodels of Huntington disease. Nat. Genet. 36:585-95
147. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, et al. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:43-47
148. Reddy PH. 2011. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 1415:136-48
149. Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, et al. 2009. Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 29:1335-47
150. Rodal AA, Blunk AD, Akbergenova Y, Jorquera RA, Buhl LK, Littleton JT. 2011. A presynaptic endosomal trafficking pathway controls synaptic growth signaling. J. Cell Biol. 193:201-17
151. Romero E, Cha GH, Verstreken P, Ly CV, Hughes RE, et al. 2008. Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57:27-40
152. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
153. Royden CS, Pirrotta V, Jan LY. 1987. The tko locus, site of a behavioral mutation in D. melanogaster, codes for a protein homologous to prokaryotic ribosomal protein S12. Cell 51:165-73
154. Rubinsztein DC. 2006. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780-86
155. Rusten TE, Simonsen A. 2008. ESCRT functions in autophagy and associated disease. Cell Cycle 7:1166- 72
156. Rusten TE, VaccariT, Lindmo K, Rodahl LM, Nezis IP, et al. 2007. ESCRTs and Fab1 regulate distinct steps of autophagy. Curr. Biol. 17:1817-25
157. Rusten TE, Vaccari T, Stenmark H. 2011. Shaping development with ESCRTs. Nat. Cell Biol. 14:38-45
158. Saini N, Oelhafen S, Hua H, Georgiev O, Schaffner W, Bueler H. 2010. Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways. Neurobiol. Dis. 40:82-92
159. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, et al. 2006. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr. Biol. 16:680-86
160. Schapira AH. 2008. Mitochondrial dysfunction in neurodegenerative diseases. Neurochem. Res. 33:2502-9
161. Schon EA, Przedborski S. 2011. Mitochondria: the next (neurode)generation. Neuron 70:1033-53
162. Seshadri S, Wolf PA. 2007. Lifetime risk of stroke and dementia: current concepts and estimates from the Framingham Study. Lancet Neurol. 6:1106-14
163. Shannon MP, Kaufman TC, Shen MW, Judd BH. 1972. Lethality patterns and morphology of selected lethal and semi-lethal mutations in the zeste-white region of Drosophila melanogaster. Genetics 72:615-38
164. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, et al. 2000. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:302-5
165. Siddiqi O, Benzer S. 1976. Neurophysiological defects in temperature-sensitive paralytic mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 73:3253-57
166. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH. 1996. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 39:203-16
167. Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. 2008. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 4:176-84
168. Skehel PA, Martin KC, Kandel ER, Bartsch D. 1995. A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269:1580-83
169. SkibinskiG, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, et al. 2005. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37:806-8
170. Slaugenhaupt SA. 2002. The molecular basis of mucolipidosis type IV. Curr. Mol. Med. 2:445-50
171. Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science 273:59-63
172. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668-72
173. Sweeney NT, Brenman JE, Jan YN, Gao FB. 2006. The coiled-coil protein shrub controls neuronal morphogenesis in Drosophila. Curr. Biol. 16:1006-11
174. Takeyama K, Ito S, Yamamoto A, Tanimoto H, Furutani T, et al. 2002. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35:855-64
175. Tanzi RE, Bertram L. 2005. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120:545-55
176. Tare M, Modi RM, Nainaparampil JJ, Puli OR, Bedi S, et al. 2011. Activation of JNK signalingmediates amyloid-β-dependent cell death. PLoS One 6:e24361
177. Teuling E, Ahmed S, Haasdijk E, Demmers J, Steinmetz MO, et al. 2007. Motor neuron diseaseassociated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 27:9801-15
178. Thiffault I, Rioux MF, Tetreault M, Jarry J, Loiselle L, et al. 2006. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. Brain 129:2332-40
179. Tonoki A, Kuranaga E, Tomioka T, Hamazaki J, Murata S, et al. 2009. Genetic evidence linking agedependent attenuation of the 26S proteasome with the aging process. Mol. Cell. Biol. 29:1095-106
180. Trinh K, Moore K, Wes PD, Muchowski PJ, Dey J, et al. 2008. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease. J. Neurosci. 28:465-72
181. Tsuda H, Han SM, Yang Y, Tong C, Lin YQ, et al. 2008. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 133:963-77
182. Underwood BR, Imarisio S, Fleming A, Rose C, Krishna G, et al. 2010. Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum. Mol. Genet. 19:3413- 29
183. Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P. 2011. Loss of Skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell 145:117-32
184. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-60
185. Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR. 2007. Inhibitors of metabolism rescue cell death in Huntington's disease models. Proc. Natl. Acad. Sci. USA 104:14525-30
186. Varma H, Yamamoto A, Sarantos MR, Hughes RE, Stockwell BR. 2010. Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. J. Biol. Chem. 285:37445-57
187. Venkatachalam K, Long AA, Elsaesser R, Nikolaeva D, Broadie K, Montell C. 2008. Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell 135:838-51
188. Venken KJ, Bellen HJ. 2005. Emerging technologies for gene manipulation in Drosophila melanogaster. Nat. Rev. Genet. 6:167-78
189. Venken KJ, Bellen HJ. 2007. Transgenesis upgrades for Drosophila melanogaster. Development 134:3571- 84
190. Venken KJ, Simpson JH, BellenHJ. 2011. Geneticmanipulation of genes and cells in the nervous system of the fruit fly. Neuron 72:202-30
191. Verghese PB, Castellano JM, Holtzman DM. 2011. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10:241-52
192. Vilain S, Esposito G, Haddad D, Schaap O, Dobreva MP, et al. 2012. The yeast Complex I equivalent NADH dehydrogenase rescues pink1 mutants. PLoS Genet. 8:e1002456
193. Vos M, Esposito G, Edirisinghe JN, Vilain S, Haddad DM, et al. 2012. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336:1306-10
194. Vos MJ, Zijlstra MP, Kanon B, van Waarde-Verhagen MA, Brunt ER, et al. 2010. HSPB7 is the most potent polyQ aggregation suppressorwithin the HSPB family of molecular chaperones. Hum. Mol. Genet. 19:4677-93
195. Walker DW, Muffat J, Rundel C, Benzer S. 2006. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr. Biol. 16:674-79
196. Wang CT, Chen YC, Wang YY, Huang MH, Yen TL, et al. 2011. Reduced neuronal expression of ribose-5-phosphate isomerase enhances tolerance to oxidative stress, extends lifespan, and attenuates polyglutamine toxicity in Drosophila. Aging Cell 11:93-103
197. Wang T, Lao U, Edgar BA. 2009. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J. Cell Biol. 186:703-11
198. Wang T, Montell C. 2007. Phototransduction and retinal degeneration in Drosophila. Pflugers Arch. 454:821-47
199. Warrick JM, Morabito LM, Bilen J, Gordesky-Gold B, Faust LZ, et al. 2005. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18:37-48
200. Warrick JM, Paulson HL, Gray-BoardGL, BuiQT, FischbeckKH, et al. 1998. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93:939-49
201. Wassef R, Haenold R, Hansel A, Brot N, Heinemann SH, Hoshi T. 2007. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. J. Neurosci. 27:12808-16
202. Wharton KA, Cook JM, Torres-Schumann S, de Castro K, Borod E, Phillips DA. 1999. Genetic analysis of the bone morphogenetic protein-related gene, gbb, identifies multiple requirements during Drosophila development. Genetics 152:629-40
203. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, et al. 2001. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293:711-14
204. Wu CF, Ganetzky B, Jan LY, Jan YN, Benzer S. 1978. A Drosophila mutant with a temperature-sensitive block in nerve conduction. Proc. Natl. Acad. Sci. USA 75:4047-51
205. Xu X, Kim SK. 2011. The early bird catches the worm: new technologies for the Caenorhabditis elegans toolkit. Nat. Rev. Genet.12:793-801
206. Yi J, Ma C, Li Y, WeislederN, Rios E, et al. 2011. Mitochondrial calcium uptake regulates rapid calcium transients in skeletal muscle during excitation-contraction (E-C) coupling. J. Biol. Chem. 286:32436-43
207. Zhai RG, Cao Y, Hiesinger PR, Zhou Y, Mehta SQ, et al. 2006. Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol. 4:e416
208. Zhai RG, Zhang F, Hiesinger PR, Cao Y, Haueter CM, Bellen HJ. 2008. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature 452:887-91
209. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, et al. 2005. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14:2063-73
210. Zhang YQ, Roote J, Brogna S, Davis AW, Barbash DA, et al. 1999. stress sensitive B encodes an adenine nucleotide translocase in Drosophila melanogaster. Genetics 153:891-903
211. Zimprich A, Biskup S, Leitner P, Lichtner P, FarrerM, et al. 2004. Mutations in LRRK2 cause autosomaldominant parkinsonism with pleomorphic pathology. Neuron 44:601-7
212. Zinsmaier KE. 2010. Cysteine-string protein's neuroprotective role. J. Neurogenet. 24:120-32
213. Ziviani E, Tao RN, Whitworth AJ. 2010. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. USA 107:5018-23